drugset / Trial / NCT06394973
Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension
RandomizedParallel-groupSingle-blindTreatment
Summary
The main purpose is to compare the ocular hypotensive efficacy and safety of two concentrations of T4090 (Kinezodianone R HCl 0.2% and 0.3%) ophthalmic solution with Rhopressa® ophthalmic solution
Timeline
- Start
- 2024-08-05
- Primary completion
- 2024-11-21
- Completion
- 2024-11-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Kinezodianone R | Unknown | 0.2 % | Other |
| Subject | Kinezodianone R | Unknown | 0.3 % | Other |
| Comparator | Netarsudil | Small molecule | 0.02 % | Other |